<SEC-DOCUMENT>0001174947-18-001233.txt : 20181128
<SEC-HEADER>0001174947-18-001233.hdr.sgml : 20181128
<ACCEPTANCE-DATETIME>20181018141817
<PRIVATE-TO-PUBLIC>
ACCESSION NUMBER:		0001174947-18-001233
CONFORMED SUBMISSION TYPE:	CORRESP
PUBLIC DOCUMENT COUNT:		2
FILED AS OF DATE:		20181018

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			CONMED CORP
		CENTRAL INDEX KEY:			0000816956
		STANDARD INDUSTRIAL CLASSIFICATION:	ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845]
		IRS NUMBER:				160977505
		STATE OF INCORPORATION:			NY
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		CORRESP

	BUSINESS ADDRESS:	
		STREET 1:		525 FRENCH ROAD
		CITY:			UTICA
		STATE:			NY
		ZIP:			13502
		BUSINESS PHONE:		315-624-3208

	MAIL ADDRESS:	
		STREET 1:		525 FRENCH ROAD
		CITY:			UTICA
		STATE:			NY
		ZIP:			13502
</SEC-HEADER>
<DOCUMENT>
<TYPE>CORRESP
<SEQUENCE>1
<FILENAME>filename1.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 4.8pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 4.8pt">&nbsp;<IMG SRC="image_001.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 4.8pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 4.8pt">October 18, 2018</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 35pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-weight: normal; font-style: normal; font-variant: normal"><U>Via
EDGAR</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Martin James, Senior Assistant Chief Accountant</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 172pt 0 0">United States Securities and Exchange Commission</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 172pt 0 0">Division of Corporation Finance</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 172pt 0 0">Mail Stop 3030</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 172pt 0 0">100 F Street, N.E.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 172pt 0 0">Washington, D.C. 20549-3030</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 172pt 0 1pt">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 0 35pt; text-align: justify; background-color: transparent">Re:
CONMED Corporation</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 11.25pt 35pt; text-indent: 1pt"><B>Form 10-K for the Fiscal Year
Ended December 31, 2017, Filed February 26, 2018<BR>
Form 10-Q for the Quarterly Period Ended June 30, 2018, Filed August 2, 2018<BR>
Form 8-K dated August 1, 2018, Filed August 2, 2018<BR>
File No. 000-16093</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 9pt 0 11.25pt; text-align: justify; background-color: white">Dear Mr.
James:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 4.5pt 8.7pt 0; text-align: justify">We are in receipt of your letter
dated September 21, 2018, regarding your review and comments on CONMED Corporation&rsquo;s filings. Following each of the SEC&rsquo;s
comments is our response.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-weight: normal; font-style: normal; font-variant: normal"><U>Form
10-Q for the Quarterly Period Ended June 30, 2018</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-weight: normal; font-style: normal; font-variant: normal"><U>Item
1. Financial Statements</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-weight: normal; font-style: normal; font-variant: normal"><U>Note
3. Revenues, page 4</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 33.85pt">1.</TD><TD STYLE="text-align: justify">We note on page 5 that the net commission percentage charged under your agreement with Musculoskeletal
Transplant Foundation can vary over the term of the agreement. Please tell us the amount of revenue recognized under this agreement
during the six-months ended June 30, 2018, and describe to us how you account for the variability in the transaction price over
the term of the agreement. In addition, explain to us the &ldquo;acquired assets&rdquo; in this arrangement and the basis for reducing
revenues for the amortization of these acquired assets over its expected useful life of 25 years.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 17pt 0 35pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 17pt 0 35pt; text-align: justify"><B><U>Response:</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 17pt 0 35pt; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 35pt; text-align: justify">We note on page 5 that the net commission
percentage charged under your agreement with Musculoskeletal Transplant Foundation can vary over the term of the agreement. Please
tell us the amount of revenue recognized under this agreement during the six-months ended June 30, 2018, and describe to us how
you account for the variability in the transaction price over the term of the agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 35pt; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 35pt; text-align: justify"><B>&nbsp;</B></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 35pt; text-align: justify"><B></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 35pt; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 35pt; text-align: justify"><B>During the six months ended June
30, 2018, we recorded net revenues of $12.3 million, including $3.0 million in amortization, under our agreement with Musculoskeletal
Transplant Foundation, Inc. (&ldquo;MTF&rdquo;). Under the terms of the agreement, MTF is responsible for the sourcing, processing
and distribution of allograft tissue for sports medicine procedures while CONMED Corporation (the &ldquo;Company&rdquo;) is responsible
for the sales representation, marketing and promotion of MTF&rsquo;s sports medicine allograft tissues to customers through our
sales force and marketing. </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 35pt; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 35pt; text-align: justify"><B>As compensation, the Company is
paid a &ldquo;Service Fee&rdquo; by MTF which is calculated as an amount equal to 50% of the amounts invoiced by MTF to customers
for sports medicine allograft tissues. Each month, we receive customer billing data from MTF and invoice MTF for our Service Fee
at 50% of what MTF has billed for shipments of allograft tissue. For this contract with MTF, the Company promises to perform the
services of: sales representation, marketing, and promotion of the tissue. In assessing these promises, the Company determined
we meet the guidance in ASC 606-10-25-15, and accounts for the services as a series of distinct performance obligations. Each service
would be recognized over time as MTF simultaneously receives and consumes the benefit (ASC 606-10-25-27a), and the Company would
use the same method to measure progress for the service which is time. Because the contract pricing is 50% of actual sales by MTF,
the amount will vary period to period (i.e. variable consideration). However, because the performance obligation qualifies as a
series, in following ASC 606-10-32-40, the Company recognizes revenue each period-end based on actual results for the service provided
that period. This is because the terms of the variable payment (i.e. the 50% of sales) relate specifically to the Company&rsquo;s
performance for that period, and allocating to each period is consistent with the allocation objective in ASC 606-10-32-28. </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 35pt; text-align: justify"><B>The agreement also provides for
a Service Fee that varies from 50% based on actual annual average selling price (&ldquo;ASP&rdquo;) billed by MTF to customers
for an allograft cartilage scaffold (&ldquo;ACS&rdquo;) product which to date has not been introduced to the market. Under the
terms of the agreement, our Service Fee percentage increases contractually according to a scale as ACS ASP increases. To the extent
the ACS product is introduced and distributed to the market, the Company will estimate the amount of consideration to which it
is entitled in accordance with ASC 606-10-32-5 based on available ASP data.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 17pt 0 35pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 8pt 0.5in; text-align: justify">In addition, explain to us the
&ldquo;acquired assets&rdquo; in this arrangement and the basis for reducing revenues for the amortization of these acquired assets
over its expected useful life of 25 years.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 8pt 0.5in; text-align: justify"><B>Under the terms of our agreement
with MTF, the Company acquired the exclusive rights to represent, market and promote MTF&rsquo;s sports medicine allograft tissues
to customers through our sales force and marketing. The assets acquired as a result of the MTF agreement consist of these exclusive
rights and have been recognized as an intangible asset under ASC 350-30-25-1. The term of our agreement with MTF is 25 years and
we are amortizing the assets acquired over their 25 year life. We determined straight-line amortization to be the appropriate method
for amortization of these assets as we expect cash flows to be relatively consistent over the term of the agreement. </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 8pt 0.5in; text-align: justify"><B>The amortization of the acquired
assets is accounted for as a reduction of revenue in accordance with ASC 606-10-32-25 which states &ldquo;an entity shall account
for consideration payable to a customer as a reduction of the transaction price and therefore, of revenue unless the payment to
the customer is in exchange for a distinct good or service&rdquo;. The Company provides sales representation, marketing and promotional
services to our customer, MTF. Since payments made for the acquired assets is directly related to the provision of these services,
the amortization of these assets is appropriately recorded as a reduction of revenue generated under the MTF agreement.</B></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 8pt 0.5in; text-align: justify"><B> </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 17pt 0 35pt; text-align: justify"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">2.</TD><TD STYLE="text-align: justify">We note from the table on page 18 that approximately 20% of your revenue is related to the sale
of capital equipment. Please describe to us the material terms of your capital equipment sales contracts and explain&nbsp;how you
account for these sales. In addition, describe to us any related contractual agreements to purchase single-use products and stand-ready
service agreements and address your accounting for these agreements under ASC 606, with appropriate references to the specific
guidance on which you relied.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 48pt 0 0.5in; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 48pt 0 0.5in; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 48pt 0 0.5in; text-align: justify"><B><U>Response:</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><B>Material terms of sale include
agreed upon equipment ordered, quantity, price and payment terms. Revenue on sales of capital equipment is recognized when the
customer obtains control upon shipment. The Company does not enter into related contractual agreements obligating a customer to
purchase single-use products. As further described below in response to comment 3, the Company may place capital equipment with
customers in return for commitments to purchase single-use products. </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 8pt 0.5in; text-align: justify"><B>The standard warranty period
on sales of our capital equipment is generally one year. These standard warranties are assurance-type warranties under ASC 606-10-55-30.
In addition, we sell extended warranty (stand ready) service contracts for a period of one to three years. These separately priced
extended warranty contracts are service-type warranties under ASC 606-10-55-30. We receive payment for the extended warranty in
advance and record a contract liability with revenue recognized over the life of the contract on a straight-line basis, which is
reflective of our obligation to stand ready to provide repair services. Our capital equipment may have recommended periodic maintenance
generally at intervals beyond the standard warranty period. Periodic maintenance is not covered under standard warranty but is
covered under extended warranty (stand ready) service contracts. The customer is not required to purchase an extended warranty
(stand ready) service contract in order to obtain periodic maintenance as it can be purchased on a one-off basis.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 56pt 0 0.5in; text-align: justify"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 1.35pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0pt"></TD><TD STYLE="width: 34.95pt">3.</TD><TD STYLE="text-align: justify">To help us better understand your accounting for the capital equipment you loan to customers, please
address the following:</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 1.35pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Describe to us the significant terms of
your agreements with your customers, including the contract period and what happens to the equipment upon termination of the contract.</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 1.35pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Describe to us the minimum purchase requirements,
including for example, whether a customer is required to make a minimum number of purchases per year, a minimum number of purchases
over the life of the agreement, or a minimum percentage of its overall purchases of the related single-use product from you.</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 1.35pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Clarify for us whether only your single-use
products can be used with your loaned capital equipment.</FONT></TD></TR></TABLE>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 1.35pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Explain to us your rights to obtain the
equipment if your customer does not meet the minimum purchase quantities.</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 1.35pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Tell us who controls and maintains title
to the capital equipment when it is at your customer's site.</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 1.35pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Tell us who incurs the costs to service
and maintain the capital equipment while it is at your customer's site.</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 1.35pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Tell us the value of the loaned capital
equipment at the time it is placed with the customer.</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 1.35pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Tell us where on your income statement
you present the amortized cost of your loaned capital equipment.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1.35pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1.35pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1.35pt 0.5in; text-align: justify"><B><U>Response:</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1.35pt 0.5in; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1.35pt 0.5in; text-align: justify">Describe to us the significant
terms of your agreements with your customers, including the contract period and what happens to the equipment upon termination
of the contract.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 12pt 1.35pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 8pt 0.5in; text-align: justify"><B>The Company places capital equipment
with certain customers on a loaned basis and at no charge in exchange for commitments to purchase single-use products over time
periods generally ranging from one to three years. Under a capital equipment placement agreement, the Company retains ownership
of the capital equipment and is contractually able to take back equipment for single-use purchasing shortfalls and contract termination.
In addition, the customer may return the equipment and cancel the placement agreement at any time upon 60 days written notice.
Each placement agreement contains standard program terms and conditions, equipment to be placed, single-use purchase commitment,
term, etc. The Company has determined that the placement agreements contain an embedded lease. Specifically, the placement agreements
convey to our customer the right to use the equipment which satisfies the conditions specified in ASC 840-10-15-6. Further, upon
applying the guidance in ASC 840-10-25-43 the Company accounts for the embedded lease as an operating lease. Since the placement
agreement is cancellable by the lessee at any time, lease revenue is variable and therefore recognized to revenue in the period
in which the single-use purchase occurs. </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1.35pt 0.5in; text-align: justify">Describe to us the minimum purchase
requirements, including for example, whether a customer is required to make a minimum number of purchases per year, a minimum number
of purchases over the life of the agreement, or a minimum percentage of its overall purchases of the related single-use product
from you.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><B>The minimum purchase requirements
are generally expressed as a unit quantity minimum purchase per year. For example, in return for the placement of a shaver console,
a customer may be required to purchase a specified number of shaver blades at a specified price on an annual basis. However, since
the placement agreement may be canceled, and the equipment returned without penalty, there is effectively no minimum purchase requirement.
</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify">Clarify for us whether only your
single-use products can be used with your loaned capital equipment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><B>&nbsp;</B></P>

<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><B></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><B>The customer is required to purchase
the single-use products directly from the Company. Only CONMED single-use products can be used with our loaned capital equipment.
</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify">Explain to us your rights to obtain
the equipment if your customer does not meet the minimum purchase quantities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><B>The Company retains ownership
of the loaned capital equipment and is contractually able to take back loaned equipment as recourse if the customer does not meet
the minimum purchase quantities. </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify">Tell us who controls and maintains
title to the capital equipment when it is at your customer's site.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 8pt 0.5in; text-align: justify"><B>The placement agreements convey
to our customer the right to use the equipment and meet the conditions specified in ASC 840-10-15-6, i.e., a) the purchaser (lessee)
has the ability or right to operate the equipment, b) the purchaser (lessee) has the ability or right to control physical access
to the equipment and c) facts and circumstances indicate that it is remote that one or more parties other than the purchaser (lessee)
will take more than a minor amount of the output &hellip;generated by the equipment. The placement agreements explicitly state
that the Company maintains ownership and title to the capital equipment. </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1.35pt 0.5in; text-align: justify">Tell us who incurs the costs
to service and maintain the capital equipment while it is at your customer's site.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 8pt 0.5in; text-align: justify"><B>The Company provides service
coverage equivalent to its standard warranty on placed equipment. The customer is responsible for service, maintenance and repair
beyond the standard warranty period. </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1.35pt 0.5in; text-align: justify">Tell us the value of the loaned
capital equipment at the time it is placed with the customer.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1.35pt 0.5in; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1.35pt 0.5in; text-align: justify"><B>The carrying value of the
loaned capital equipment at the time it is placed with the customer is amortized cost.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1.35pt 0.5in; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1.35pt 0.5in; text-align: justify">Tell us where on your income
statement you present the amortized cost of your loaned capital equipment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 8pt 0.5in; text-align: justify"><B>Amortization of loaned capital
equipment is presented in selling and administrative expense as a cost of obtaining single-use product sales and totaled approximately
$1.0 million in the quarterly period ended June 30, 2018. </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 2in 1.35pt 1pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-weight: normal; font-style: normal; font-variant: normal"><U>Management's
Discussion and Analysis of Financial Condition and Results of Operations Consolidated Results of Operations, page 17</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 1.35pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">4.</TD><TD STYLE="text-align: justify">We note that on page 18 you present the change in sales 'as reported' and 'as adjusted' but did
not provide the reconciliation of the non-GAAP measure to the comparable GAAP measure as required by Item 10(e)(1)(i)(B) of Regulation
S-K. Please revise your future filings to comply with that guidance.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 12pt 1.35pt 0.5in; text-align: justify">&nbsp;</P>

<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 12pt 1.35pt 0.5in; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 12pt 0 0.5in; text-align: justify"><B><U>Response:</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 3pt 0 35pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 3pt 0 35pt; text-align: justify"><B>In future filings, we will include
a reconciliation of &lsquo;as reported&rsquo; to &lsquo;as adjusted&rsquo; sales to ensure we reconcile GAAP to non-GAAP measures.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 3pt 0 35pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 3pt 12.15pt 35pt; text-align: justify; text-indent: -35pt"><U>Form
8-K dated August 1, 2018 </U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 3pt 12.15pt 35pt; text-align: justify; text-indent: -35pt"><U>Exhibit
99.1, page 1</U></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12.15pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 2pt"></TD><TD STYLE="width: 34pt">5.</TD><TD STYLE="text-align: justify">In the highlights section of your earnings release you disclose that adjusted gross margin increased
190 basis points year over year to 54.6% but you did not provide the reconciliation of the non-GAAP measure to the comparable GAAP
measure as required by Item 10(e)(1)(i)(B) of Regulation S-K.&nbsp; Please revise your future filings to comply with that guidance.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 12pt 0 0.5in; text-align: justify"><B><U>Response:</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 13pt 0 0.5in; text-align: justify; text-indent: -1pt"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -1pt"><B>In the quarterly
period ended June 30, 2018, GAAP gross margin and adjusted gross margin were the same. A reconciliation of GAAP to non-GAAP measures
including gross margin (for comparative prior year periods) is included on page 7 of our earnings release. In future filings we
will reword &ldquo;Gross profit %&rdquo; to &ldquo;Adjusted gross profit %&rdquo;.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 13pt 0 0.5in; text-align: justify; text-indent: -1pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 16.85pt; text-align: justify">We acknowledge the company and
its management are responsible for the accuracy and adequacy of  our disclosures, notwithstanding any review, comments,
action or absence of action by the staff.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 16.85pt; text-align: justify">Thank you for your consideration.
Please feel free to contact me at (315) 624-6317 should you have any questions or comments relative to this response or any other
matter.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 13pt 16.85pt 0">Regards,</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 13pt 16.85pt 0">/s/ Todd W. Garner</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 13pt 16.85pt 0">Todd W. Garner<BR>
Executive Vice President &amp;<BR>
Chief Financial Officer</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 8pt">&nbsp;</P>

<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 8pt"></P>



<P STYLE="margin: 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>image_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_001.jpg
M_]C_X  02D9)1@ ! 0$ > !X  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" !C 9$# 2(  A$! Q$!_\0
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M#2<J,&][+\@IDTT5O"\TTB1Q(I9W=@%4#J23T%-N;F&SM9;FYE2*"%"\DCG
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M'_A^?I7I$TMMIMB\LA2"U@3)P,*BCVKRL5F*B^2CJ^Y[6#RIR7M*^B[?Y]C
ML=$T#P/IDEZ^T,B_O+J7EV/H/3/H*\Q\5^-+SQ),84W6^GJ?D@!Y;W?U/MT'
MZU!XL\4W/B;42Y+1V41(@A]!_>/^T?TZ5S]:X7".+]K5UE^1CC<<I+V-#2"_
M$****] \L**** /=/AY_R)-A]9/_ $-JZBN7^'G_ ")-A]9/_0VKJ*^2Q/\
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MC:2EECGN[>)BO4!HXP<>_- 'TEX%\<:;XZT);^R81SIA;FV8Y:%_3W!['O\
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M'X9PW2J!)?7$LSMW.#L _P#'?UK'_:0L9)O".E7JKE;>\*/[!T//YJ/SK9^
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M6-0J*%4= !@4ZL*N:5):05OQ.FCDU&.M1\WX&#H?@_1M  >UM@]P.L\WS/\
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M7UE\3O"H\7^!+_3XTW7D2_:+7U\U>0!]1E?^!5\X?![PF?%'C^U6>+=9:?\
MZ5< C@[3\JGZMCCT!H ^B_A9X4'A'P'8V<D>V\G'VFZXY\Q@.#_NC"_A7:44
M4 ?/'[2NF[=0T'5%7B2*2W<_[I##_P!":I?ASJ?VK]GOQ98L?FLHKD >BO'N
M'Z[JZO\ :#TW[9\.%NPN6LKR.0GT5LH?U85Y)\+=2\OPOX^TLMQ/HLEP!_N
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M(Y$EC62-@R. RL#P0>AKU<VB_:1ETL>+DDTZ,H];CJ***\H]H**** "BBB@
MHHHH ***J7^IV.EVYGOKJ*WC'>1L9^@ZG\*:3;LA-J*NRW15+2M4MM9T^.^L
MRQ@D+!2RX)P2.GX5=H:<79A&2DKK8**R=6T:?4IDDBU>]L@J[2EN^ WN?>L_
M_A%+S_H9]7_[^BM(P@U=RM\F8RJ5$[*%_FCH;BV@NX&@N88YH7&&CD0,I^H-
M<;J/PA\":DY>7P_!$Y.<VSO#^BD#]*T?^$4O/^AGU?\ [^BC_A%+S_H9]7_[
M^BJ]G3_G_!B]K5_Y]O[T8=M\$? -M('_ +%:4CH);F5A^6ZNQTG0=(T*#R=)
MTVULHSU$$03=]2.3^-97_"*7G_0SZO\ ]_11_P (I>?]#/J__?T4>SI_S_@P
M]K5_Y]O[T=-17,_\(I>?]#/J_P#W]%'_  BEY_T,^K_]_11[.G_/^##VM7_G
MV_O1O7MA9ZE;-;WUI!=0-UCGC#J?P-<G/\)/ =Q(9'\-VH8]HV=!^2L!5[_A
M%+S_ *&?5_\ OZ*/^$4O/^AGU?\ [^BCV=/^?\&'M:O_ #[?WH=I7P_\):)*
M)=/\/V,4J_=D:+>X^C-DBNDKF?\ A%+S_H9]7_[^BC_A%+S_ *&?5_\ OZ*/
M9T_Y_P &'M:O_/M_>CIJR+GPMX?O-0.H7.B:=->%@QN)+9&<D8P=Q&<C _*J
M'_"*7G_0SZO_ -_11_PBEY_T,^K_ /?T4>SI_P _X,/:U?\ GV_O1TU%<S_P
MBEY_T,^K_P#?T4?\(I>?]#/J_P#W]%'LZ?\ /^##VM7_ )]O[T=-17,_\(I>
M?]#/J_\ W]%'_"*7G_0SZO\ ]_11[.G_ #_@P]K5_P"?;^]%O6_">C^(+VRO
M+^V#W%GO$<BG!*.I5D)[J0QX_*L[3/AGX-T?4H-0T_0H(+N!MT4@=R5/3/+8
MJ;_A%+S_ *&?5_\ OZ*/^$4O/^AGU?\ [^BCV=/^?\&'M:O_ #[?WHZ:BN9_
MX12\_P"AGU?_ +^BC_A%+S_H9]7_ ._HH]G3_G_!A[6K_P ^W]Z.FKG/#'@W
M3O"MYK5S8CY]4NS<O\N-@QP@]@2Q_P"!4S_A%+S_ *&?5_\ OZ*/^$4O/^AG
MU?\ [^BCV=/^?\&'M:O_ #[?WHZ:BN9_X12\_P"AGU?_ +^BC_A%+S_H9]7_
M ._HH]G3_G_!A[6K_P ^W]Z-K5=*L=<TR;3=2MEN;.< 21,3AL$$=.>H%86E
M_#?P?HUQ)/8:%;Q22Q-#)EF8.C<,I#$@@T__ (12\_Z&?5_^_HH_X12\_P"A
MGU?_ +^BCV=/^?\ !A[6K_S[?WHF_P"$$\(_]"QH_P#X!1_X4?\ "">$?^A8
MT?\ \ H_\*A_X12\_P"AGU?_ +^BC_A%+S_H9]7_ ._HH]G3_G_!A[6K_P ^
MW]Z)O^$$\(_]"QH__@%'_A5V^\.:)J<-O#?Z18W45LNR!)K=7$0P!A01P.!T
M]*S/^$4O/^AGU?\ [^BC_A%+S_H9]7_[^BCV=/\ G_!A[6K_ ,^W]Z)O^$$\
M(_\ 0L:/_P" 4?\ A5ZS\/Z+ISA[+2+"V8=&AMD0_H*R_P#A%+S_ *&?5_\
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M !HHH]K/NP]E3_E7W!_8.F?\^H_[[;_&C^P=,_Y]1_WVW^-%%'M9]V'LJ?\
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$4 ?_V0$!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
